• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • About
  • Our Products
    • Restoret
  • Team
EyeBio

EyeBio

  • Business Development
  • News
  • Contact

Back to Team

Laura Kupsch

Vice President of Quality Assurance

LinkedIn

Laura Kupsch joined EyeBio as the Vice President Quality Assurance in 2023. She is responsible for providing strategic direction for the company’s quality operations including compliance of contract organizations and the development, implementation, and maintenance of the overall Quality Management System in accordance with appropriate regulatory requirements.

Laura has more than 25 years of GxP industry experience, including several years at emerging companies focused on retinal diseases. In her previous role as Vice President, Quality Assurance, at Passage Bio, she led a team responsible for ensuring GxP compliance of all product development and testing.

Laura received her Doctorate in Regulatory Sciences from the University of Southern California, as well as a Master of Science degree from Temple University and an MBA from Marist College.

Footer

Contact Us

Please fill out the brief form below with any questions or inquiries, and a member of our team will connect with you soon.

Business Development

EyeBio is bringing disruptive innovation to the field of ophthalmology. We actively seek to expand our pipeline of promising investigational therapies, and we welcome inquiries regarding in-licensing and acquisition of assets into our portfolio.

To learn more, please contact Sarah Milsom, Chief Operating Officer of EyeBio, at s.milsom@nulleyebiotech.com.

Privacy Policy
Terms of Use
Cookie Policy
Accessibility Statement

EyeBio

LinkedIn

Copyright © 2022 EyeBio

logo
  • About
  • Our Products
    • Restoret
  • Team
  • Business Development
  • News
  • Contact